title: Management of locally advanced rectal cancer.
abstract: The treatment of rectal cancer typically involves a multidisciplinary approach. A minority of patients will have tumors that are full thickness, involve adjacent structures, or have metastatic disease to regional lymph nodes. The combination of adjuvant therapy and surgical resection is the mainstay of treatment for locally advanced carcinoma of the rectum. This article will review the role of adjuvant chemotherapy and radiotherapy in patients with high risk tumors. The operative considerations in advanced rectal cancers will be reviewed. In particular, the role of mesorectal excision and exenterative surgery will be discussed.
authors.affiliation: Department of Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA.
authors.forename: A R
authors.initials: AR
authors.lastname: Sasson
authors.forename: E R
authors.initials: ER
authors.lastname: Sigurdson
mesh_terms: D017024:Chemotherapy, Adjuvant; D006801:Humans; D008197:Lymph Node Excision; D010385:Pelvic Exenteration; D011183:Postoperative Complications / Q000453:epidemiology; D016737:Proctocolectomy, Restorative; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012007:Rectum / Q000601:surgery; D015996:Survival Rate